Connect your AI

HNGE HNGE Long-term marketable securities

Long-term marketable securities at other companies

Globus MedicalGMED

——

Hims & Hers HealthHIMS

——

Other financials

Income statement

Revenue$182.3M+47.2%

Gross profit$154.2M+53.9%

Operating income$32.1M+144%

Net income$35.1M+105%

EPS (diluted)$0.41-68.7%

Balance sheet

Cash & equivalents$188.1M-35.2%

Total debt$7.0M—

Total equity$111.7M+136%

Total assets$728.8M—

Cash flow

Operating cash flow$43.1M+775%

CapEx$83.0K+62.7%

Free cash flow$43.0M+782%

Valuation

Market cap$5.37B—

Enterprise value$5.19B—

P/S8.3×—

Profitability

Gross margin80.8%+1.5pp

Operating margin-85.8%—

Net margin-83.9%—

FCF margin32.3%—

Returns & leverage

Return on equity551.8%—

Debt / equity0.1×—

Current ratio1.3×—

Where this comes from

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about HNGE's long-term marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is HNGE's long-term marketable securities?: HNGE (HNGE) reported long-term marketable securities of $89.77M in Q1 2026.